Strides Arcolab + Kale Consultants

Strides Arcolab has announced its first ANDS approval for ondansetron injection 2 mg / ml. Ondansetron is a first amongst various sterile submissions the company has submitted with health Canada and the product is licensed to an undisclosed partner in Canada and expects sales to commence in Q4 2007.

Kale Consultants has announced the company’s acquisition of privately held Zero Octa, the largest and leading provider of airline revenue assurance, protection and audit services world wide.

Zero Octa, headquartered in London, is a strategic addition to the company’s revenue management portfolio aimed specifically at the airline industry. The acquisition will extend the company’s revenue management, protection and revenue integrity service capabilities and also significantly increases the company’s airline client base. Zero Octa offers a fully managed end-to-end solution that works in conjunction with an airlines’ existing processes to maximize the efficiency of their systems, processes and personnel.

The acquisition will make Kale Consultants not only the leading, but also the largest provider of revenue management and accounting solutions globally. With over 200 domain, technology and software professionals and 1100 processing staff the company will have the largest pool of expertise in this space globally.